N-(quinuclidin-3-YL)-1,8,-naphthalimides with 5-HT3 receptor antagonist and 5-HT4 receptor agonist properties
- 1 June 1993
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 3 (6) , 1375-1378
- https://doi.org/10.1016/s0960-894x(00)80352-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- N-(quinuclidin-3-YL)-1,8,-naphthalimides with 5-HT3 receptor antagonist and 5-HT4 receptor agonist propertiesBioorganic & Medicinal Chemistry Letters, 1993
- The 5-HT4 receptor: a place in the sunTrends in Pharmacological Sciences, 1992
- Indazole as an indole bioisostere: 5-HT4 receptor antagonism.Bioorganic & Medicinal Chemistry Letters, 1992
- Derivatives of naphthalimide: new potent conformationally restricted antagonists of 5-HT3 receptors.Bioorganic & Medicinal Chemistry Letters, 1992
- SC-53116: the first selective agonist at the newly identified serotonin 5-HT4 receptor subtypeJournal of Medicinal Chemistry, 1992
- Pharmacological and histological examinations of regional differences of guinea‐pig lung: a role of pleural surface smooth muscle in lung strip contractionBritish Journal of Pharmacology, 1992
- Design and synthesis of novel ligands for the 5-HT3 and the 5-HT4 receptorBioorganic & Medicinal Chemistry Letters, 1992
- SDZ 205–557, a selective antagonist at 5-HT4 receptors in the isolated guinea pig ileumEuropean Journal of Pharmacology, 1991
- Azabicycloalkyl benzimidazolones: Interaction with serotonergic 5-HT3 and 5-HT4 receptors and potential therapeutic implicationsDrugs of the Future, 1991
- Mediation of 5‐hydroxytryptamine‐induced tachycardia in the pig by the putative 5‐HT4 receptorBritish Journal of Pharmacology, 1990